Life science investor adjusts organization to stay on top of its game
![Photo: PR / Healthcap/Dan Coleman AB](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13360692.ece/ALTERNATES/schema-16_9/doc7hxkdsj5jq99l1kd36r.jpg)
Swedish venture capital firm Healthcap specializes in investing in companies that try to find and develop medical solutions to serious diseases such as cancer and genetic diseases.
It's a strategy the firm has had for a long time, and the decision was recently made to expand the team and promote several new partners to advance the efforts.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Analyst on Ambu downgrade: Doesn't change investment case
For subscribers